Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

July 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Cardiovascular disease risks in chemotherapy-treated testicular cancer patients

AIIMS Delhi Research Assistant & Scientist Recruitment | Applications Invited

ICAR-NBPGR Research Recruitment – Junior Research Fellow Job

Cardiovascular disease risks in chemotherapy-treated testicular cancer patients
  • BiotechToday
  • World

Cardiovascular disease risks in chemotherapy-treated testicular cancer patients

bioxone October 6, 2020October 5, 2020

PRAGYA SANTRA, AMITY UNIVERSITY KOLKATA

Genetic variation is promoting the risk of cardiovascular disease (CVD) in chemotherapy-treated testicular cancer (TC) patients due to alterations of SNPs (Single Nucleotide Polymorphism) from normal sequences. TC patients treated with platinum-based chemotherapy (PBC) when genotyped, were analyzed with 141 independent genomic loci, containing 324 SNPs contributing to CVD occurrence. Studies revealed patients attributed to bleomycin, etoposide, and cisplatin chemotherapy are prone to the coronary artery and atherosclerotic disease. Isolating germline DNA and SNP array was performed for genotyping analysis.

SNPs in glutathione-S-transferase genes GSTP1 and GSTM3 resulted in neurotoxicity and ototoxicity in platinum-treated TC patients. 5-α-reductase type-II (SRD5A2) genes associated with SNPs caused the metabolic syndrome. A recent study in 188 platinum-treated TC patients reported an SNP in the solute carrier gene, SLC16A5, resulting in cisplatin-induced ototoxicity. SNP in the Wolframin ER transmembrane glycoprotein (WFS1) leads to ototoxicity in TC survivors. All these focus on genetic variation and biological pathways to analyze the risk for CVD in TC patients treated with PBC.

Input data analyzed for Data-driven Expression Prioritized Integration for Complex Trait (DEPICT) framework, examined genes in loci comparing them to share gene set memberships to predict similar functions directing autosomal loci not overlapping with the MHC region, resulted in 187 genes mapped to 129 loci. Gene set enrichment analysis was conducted to understand the biology between SNPs and CVD occurrence, reporting 33 gene sets. Most enriched gene sets were the RAC2/RAC3 sub-networks, linking to chemotherapy toxicity, resulting in endothelial activation, by oxidized low-density lipoprotein in the human umbilical vein and dysfunction where several circulating endothelial cells were measured in 60 patients. Further analysis resulted in ten biological themes highlighting the pathways involved in the occurrence of CVD in chemotherapy-treated TC patients which includes the RAC2/RAC3 network, metabolism and adiposity, immune response, and caspase-cascade/apoptosis. 

Additionally, RAC2 leads to neovascularization and leukocyte adhesion to the endothelial cell. According to the atherosclerosis model, Rac2 suppressed macrophage IL-1β expression preventing plaque calcification. Contrarily, decreased RAC2 expression, and increased IL-1β resulted in calcifying coronary arteries. SNPs in RAC2 lead to cardiotoxicity due to anthracycline chemotherapy. RAC3 inhibits senescence and induces inflammatory response after TNF stimulation. Moreover, Rac3 modifies the induction of endothelial dysfunction.

Concluding, the RAC2/RAC3 network plays a role in atherosclerosis and senescence leading to the progression of CVD in TC patients. SNP analysis in CVD and TC patients’ population-wise focuses on the differences of SNPs. Concentrating on genetic variants is now a promising approach for future studies on genetic susceptibility considering relevant biomarkers in CVD in TC patients.

Also read: The Nobel Prize in Medicine or Physiology 2020- awarded jointly to a triad for discovering the Hepatitis C Virus!

SOURCES:

  1. Genome-wide association study of cardiovascular disease in testicular cancer patients treated with platinum-based chemotherapy; Lars C. Steggink, et al, 03 October 2020; The Pharmacogenomics Journal; DOI: https://doi.org/10.1038/s41397-020-00191-8 
  2. Vascular damage in testicular cancer patients: A study on endothelial activation by bleomycin and cisplatin in vitro; Janine Nuver et al; January 1, 2010; Oncology Reports; Volume 23; Issue 1; Pages: 247-253; DOI: https://doi.org/10.3892/or_00000630 
  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged cardiovascular disease (CVD) chemotherapy-treated genotypes platinum-treated Single Nucleotide Polymorphism (SNPs) testicular cancer (TC) toxicity

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

ICAR-NBPGR Research Recruitment – Junior Research Fellow Job

bioxone October 6, 2020

-Shristi Sharma, Team bioXone ICAR-NBPGR Research Recruitment – Junior Research Fellow Job. MSc Biotechnology, Molecular Biology, Biochemistry, Botany, Microbiology, Plant Genetic Resources & Life Science Jobs. Interested and eligible candidates can check job details, application procedure and such below: I.C.A.R.-NATIONAL BUREAU OF PLANT GENETIC RESOURCES Regional Station, Umiam – 793 103 Meghalaya (India) Ph : […]

Related Post

  • BiotechToday
  • World

Can PRESENCEOF HYALURONAN be used as a treatment option in COVID19 patients?

bioxone October 7, 2020October 7, 2020

Arpita Adhikary, Amity University Kolkata Deterioration of the respiratory system mainly the lungs is prominent in SARS COVID-19. An active agent, a jelly-like substance was found in dead COVID 19 patients’ respiratory system.  A novel fact is established by the researchers as they conducted an experiment comparing the diseased lung tissue of COVID patients and […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Smarter the bird, greater the welfare requirements in captivity

BioTech Today October 19, 2021October 19, 2021

Nandini Pharasi, Jaypee Institute of Information Technology This research is the first to show that intelligent animals can fight in captivity. According to an early study at the University of Guelph, the smarter the bird, the more pronounced the welfare requirements in captivity. For the first time, the study found that more intellect, which is […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Manufacturing Synthetic Polymers from Modified Virus-Resistant Bacteria

BioTech Today June 12, 2021June 12, 2021

Subhajit Nan, Amity University, Kolkata Scientists created modified virus-resistant bacteria and made synthetic polymers from synthetic building blocks, making them immune to viral attack. They also found the synthetic genome made the bacteria fully proof against infection by viruses. Using the natural protein-making processes of the cell The goal was to utilize the newly available […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy